
Kolosis BIO Announces the Appointment of Michelle Soleimani-Mafi as Director of Operations
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Michelle Soleimani-Mafi as its Director of Operations.
It’s Time to Upgrade your Orthobiologics Options
Kore Fiber approved in over 40 health systems
Kolosis bone grafts on shelf in more than 270 hospitals
Kore and Prime HD utilized in over 6000 fusion procedures
Kolosis grafts on hospital shelves in Canada and 46 states
Why Choose MTF Grafts?
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Michelle Soleimani-Mafi as its Director of Operations.
Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.
Salt Lake City, Utah, – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the relocation of its global headquarters to the historic Seed Building in downtown Salt Lake City.